Overview

Emergence Agitation of Sevoflurane in Pediatric

Status:
COMPLETED
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
Low dose nalbuphine versus dexmedetomidine on prevention of emergence agitation in children
Phase:
PHASE2
Details
Lead Sponsor:
Ain Shams University
Treatments:
Dexmedetomidine
Nalbuphine